The DOI matches its Crossref record; 92 of the 93 references it cites were found in a registry or an index.
Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy
Abstract
In the last decade the serotonin transporter gene promoter polymorphism (5-HTTLPR) was likely the most studied genetic variant as predictor of antidepressant response. Nevertheless results are not consistent across studies and previous meta-analysis, since various factors seem to modulate its effect on antidepressant response. With the aim of clarifying this issue, we systematically reviewed literature, selecting 33 studies for an exploratory analysis without any a priori hypothesis. Then we analyzed separately 19 studies performed on Caucasians and 11 on Asians. We tested two phenotypes--remission and response rates--and three genotype comparisons--ll versus ls/ss, ss versus ll/ls and ll versus ss - using the Cochrane review manager. Evaluations were performed separately for SSRIs and mixed/other drugs. Possible clinical modulators were investigated. In the exploratory analysis, we found an association between l allele and l/l genotype and remission. When the analysis was split for ethnic group, in Caucasians we found an association between l allele and both response (OR = 1.58, C.I. 1.16-2.16, p = 0.004), and remission (OR = 1.53, C.I. 1.14-2.04, p = 0.004) in the SSRI group. Only a marginal association between l allele and remission (OR = 1.41, C.I. 1.02-1.95, p = 0.04) survived pooling together mixed antidepressant treatments. In Asians, a small effect of 5-HTTLPR on remission for mixed antidepressants was detected (OR = 2.10, C.I. 1.15-3.84, p = 0.02). Gender, age and age at onset modulated the association in Caucasians. Gender, age and depression severity at baseline modulated the association in Asians. In conclusion, in Caucasians 5-HTTLPR may be a predictor of antidepressant response and remission, while in Asians it does not appear to play a major role.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pharmacogenetics studies have shown an association between certain polymorphisms in SLC6A4 and the response to antidepressants in patients with mood disorders.”
From Epigenetic mechanisms of major depression: Targeting neuronal plasticity (2018) · cites this paper as [131]
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
(2014) · Medical Entomology and Zoology · Cited by 17,633
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
Meta-analysis: Principles and procedures
Egger, M., Smith, G. D., & Phillips, A. N. (1997) · BMJ · doi:10.1136/bmj.315.7121.1533 · Cited by 2,415
Allelic Variation of Human Serotonin Transporter Gene Expression
Heils, A., Teufel, A., Petri, S., Stöber, G., Riederer, P., Bengel, D., & Lesch, K. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062621.x · Cited by 2,221
Hu, X.-Z., Lipsky, R., Zhu, G., Akhtar, L. A., Taubman, J., Greenberg, B., Xu, K., Arnold, P., Richter, M., Kennedy, J., et al. (2006) · American Journal of Human Genetics · doi:10.1086/503850 · Cited by 1,215
Kirchheiner, J., Nickchen, K., Bauer, M., Wong, M.-L., Licinio, J., Roots, I., & Brockmöller, J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001494 · Cited by 728
The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants
Nakamura, M., Ueno, S., Sano, A., & Tanabe, H. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000698 · Cited by 636
Smeraldi, E., Zanardi, R., Benedetti, F., Bella, D. D., Pérez, J., & Catalano, M. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000425 · Cited by 614
Serretti, A., Kato, M., De Ronchi, D., & Kinoshita, T. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001926 · Cited by 529
Self-citation
Cited by
Sorted by citations
Items 301–331 of 331
Finley, P. R., Lê, J., & Lee, K. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-27883-4_9 · Cited by 1
Laux, G. (2016) · Springer eBooks · doi:10.1007/978-3-642-45028-0_67-1
Stoltenberg, S. F. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108768412.006
Emotion and Depressive Disorders
Stoltenberg, S. F. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108768412.013
Behaviors and Behavioral Disorders
Stoltenberg, S. F. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108768412.010
Stoltenberg, S. F. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108768412.009
(2022) · Elsevier eBooks · doi:10.1016/b978-3-437-23673-0.00005-7
Kennedy, S. H., & Rizvi, S. J. (2015) · Springer eBooks · doi:10.1007/978-3-642-36172-2_380
(2015) · Elsevier eBooks · doi:10.1016/b978-3-437-23671-6.00005-5
Shabbir, S., Islam, A., Zohaib, A., Fatima, T., Riaz, S., & Malik, U. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22166834
THE INFLUENCE OF PHARMACOGENETICS IN THE CLINICAL USE OF ANTIDEPRESSANTS
Çevlik, Ö., & Kaşkal, M. (2022) · Kocatepe tıp dergisi. · doi:10.18229/kocatepetip.892349
Pharmacogenomics testing: An overview
Tariq, L., Rasool, S., Arafah, A. M., Sehar, N., Nisar, B., Alsuwayni, B. M., Rehman, M. U., & Bhat, K. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15336-5.00008-7
Psicotrópicos y Farmacogenética
Piedimonte, L., & Helguero, D. F. (2021) · NeuroTarget · doi:10.47924/neurotarget202115
MODERN ASPECTS OF PHARMACOGENETICS: FROM THEORY TO PRACTICE IN PERINATOLOGY AND PEDIATRICS
Skavinska, O., Cherniavska, Y. I., Cherniavska, Y. I., Fishchuk, L., Pokhylko, V. I., Yevseienkova, O., & Rossokha, Z. I. (2023) · Neonatology surgery and perinatal medicine · doi:10.24061/2413-4260.xiii.4.50.2023.20
Николаевич, П. К., Агибалова, Т. В., Buzik, O. Z., & Masyakin, A. V. (2024) · Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery) · doi:10.33920/med-01-2403-09
Progress in Biomarkers to Improve Treatment Outcomes in Major Depressive Disorder
Vaccarino, S. R., Ceniti, A. K., Rotzinger, S., & Kennedy, S. H. (2024) · Cambridge University Press eBooks · doi:10.1017/9781108973922.024
Cultural and Ethnic Perspectives in Psychopharmacology
Lin, K., Braakman, M. H., Shimoda, K., & Yasui‐Furukori, N. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_131
Ethnic aspects in pharmacological treatment of suicidality
Döring‐Brandl, E. J. (2024) · doi:10.1093/med/9780198843405.003.0024
Гареева, А. Э., Borodina, L., Mikhailova, E. G., Pozdnyakov, S. A., & Тимербулатов, И. Ф. (2025) · Pharmacogenetics and Pharmacogenomics · doi:10.37489/2588-0527-2025-1-9-16
Lin, S.-C., Fang, C., Hsu, C., Chung, A.-N., Chen, T., Hsu, K.-H., Yeh, C.-C., Zheng, J., Liu, C.-Y., Wu, C., et al. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02269-y
Ellerbrock, I., Sandström, A., Tour, J., Fanton, S., Kadetoff, D., Schalling, M., Jensen, K. B., Sitnikov, R., & Kosek, E. (2021) · Figshare · doi:10.6084/m9.figshare.14583416
Ellerbrock, I., Sandström, A., Tour, J., Fanton, S., Kadetoff, D., Schalling, M., Jensen, K. B., Sitnikov, R., & Kosek, E. (2021) · Figshare · doi:10.6084/m9.figshare.14583419
Ellerbrock, I., Sandström, A., Tour, J., Fanton, S., Kadetoff, D., Schalling, M., Jensen, K. B., Sitnikov, R., & Kosek, E. (2021) · Figshare · doi:10.6084/m9.figshare.14583413
Ellerbrock, I., Sandström, A., Tour, J., Fanton, S., Kadetoff, D., Schalling, M., Jensen, K. B., Sitnikov, R., & Kosek, E. (2021) · Figshare · doi:10.6084/m9.figshare.14583422
Chouhan, A., Rawat, M., & Sandhu, S. (2026) · Indian Journal of Psychological Medicine · doi:10.1177/02537176251414904
Mécanismes moléculaires à l'origine de la dysautonomie familiale
Hervé, M. (2016) · theses.fr (ABES) · doi:10.70675/6564ee49z2810z4387zb80azee2206033835
Okada, S., Shirai, T., Miyachi, M., Yamasaki, G., Minami, K., Tsukamoto, R., Mouri, K., Tanifuji, T., Katada, R., Okazaki, S., et al. (2026) · Neuropsychopharmacology Reports · doi:10.1002/npr2.70120
Generalized anxiety disorder: genetic and biochemical aspects of the serotonin transporter protein
Tozzi, N., & de Rezende, A. A. A. (2025) · Open Access Journal of Science · doi:10.15406/oajs.2025.08.00272
Individualized pharmacogenomics for depressive episodes: A narrative review
HADDAD, M., Dieckmann, L. H. J., Hoss, G. R. W., Mari, J. D. J., Young, A. H., & Juruena, M. F. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122261
Metadata
- Authors
- Porcelli, S., Fabbri, C., & Serretti, A.
- Affiliations
- University of Bologna (IT)
- Corresponding author
- Serretti, Alessandro
- Venue
- European Neuropsychopharmacology
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 22
- Issue
- 4
- Pages
- 239-258
- ISSN
- 0924-977X (ISSN-L)
- OpenAlex
- W2035090322
- Cited by
- 331
- References
- 93
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 8 · 2023: 18 · 2022: 18 · 2021: 24 · 2020: 19 · 2019: 20 · 2018: 31 · 2017: 27 · 2016: 42 · 2015: 33 · 2014: 27 · 2013: 36 · 2012: 13
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- 5-HTTLPR, serotonin transporter gene, promoter polymorphism, antidepressant response, antidepressant remission, genetic predictors of treatment response, selective serotonin reuptake inhibitors, ethnic differences, Caucasians, Asians, age of onset, depression severity, sex differences
- MeSH terms
- Age Factors, Alleles, Antidepressive Agents, Depression, Female, Genotype, Humans, Male, Polymorphism, Genetic, Promoter Regions, Genetic, Remission Induction, Sex Factors, White People, Asian People, Serotonin Plasma Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review